Global Health Dialogues with Princess Dina Mired: Amgen’s CMO Paul Burton
In this episode of Global Health Dialogues, Princess Dina Mired speaks with Dr. Paul Burton, Chief Medical Officer at Amgen, as they dive deep into the world of biotechnology, patient-first innovation, and global health. With a career that spans from cardiovascular surgery to guiding global health responses at Moderna during the COVID-19 pandemic, Dr. Burton shares insights into the rapidly evolving landscape of medical innovation and access to care worldwide.
What You’ll Learn in This Episode:
Leadership in Biotechnology: How Dr. Burton’s transition from clinical practice to leading medical teams at Amgen helps shape the future of patient care on a global scale.
Role of a Chief Medical Officer: Dr. Burton reveals his daily responsibilities as CMO at Amgen, overseeing key areas like global patient safety, regulatory affairs, and medical affairs, all while keeping patient needs at the forefront of his work.
Access to Medicines: Learn about Amgen’s commitment to global public health, providing life-saving treatments to low and middle-income countries, and their work with initiatives like the City Cancer Challenge.
Overcoming Global Health Disparities: How Amgen is addressing healthcare inequities by ensuring that innovations are accessible to patients worldwide—and how their long-term commitment to access is creating sustainable change.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023